Hallek Interview Part 2: Treatment of CLL

Creative Commons License

Transcript of Hallek Interview Part 2: Treatment of CLL

Created Date: July 07, 2009

Description: Dr. Michael Hallek discusses treatment of high-risk Binet stage A CLL patients and their inclusion in clinical trials performed by the German CLL Study Group (DCLLSG), the controversy over the inclusion of monoclonal B-cell lymphocytosis (MBL) in the iwCLL’s revision to the National Cancer Institute–sponsored Working Group’s (NCI-WG) 1996 guidelines, and the role of splenectomy in CLL treatment.

Creator: Gerald Marti

Contributor: Michael Hallek

Identifier: Hallek02_treatment

Coverage: 1996-2009

Subject: Treatment, Clinical Research

Related: Hallek01_collaboration, Hallek03_research

Series: Hallek Oral Histories

Type: Video

Rights: This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

%d bloggers like this: